Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and Johnson's Baby Shampoo but also has extensive operations in pharmaceutical development and medical device manufacturing. Long-time shareholders have seen strong returns, and a big portion of their gains has been due to the dividend payments they've received. Yet despite a rising share price, Johnson & Johnson hasn't done a stock split in 16 years. Let's take a closer look at Johnson & Johnson and whether now could be the time to change that pattern.
Johnson & Johnson definitely hasn't avoided splits throughout its history. On many occasions over the years, the healthcare conglomerate has made moves to split its shares.
Date of Split
Source: Fool.com
Johnson & Johnson Stock
The stock is one of the favorites of our community with 39 Buy predictions and 1 Sell predictions.
With a target price of 179 € there is a slightly positive potential of 19.43% for Johnson & Johnson compared to the current price of 149.88 €.
